Mycobacterium Infections [clinicaltrials_resource:c0b65b3beaf5acdac1e7869e44890a25]
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. [clinicaltrials:NCT00000641]A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS [clinicaltrials:NCT00000644]The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients [clinicaltrials:NCT00000860]Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy [clinicaltrials:NCT00000883]A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection [clinicaltrials:NCT00000895]A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients [clinicaltrials:NCT00000907]Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048 [clinicaltrials:NCT00000933]A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients [clinicaltrials:NCT00000947]The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS [clinicaltrials:NCT00000971]The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients [clinicaltrials:NCT00001023]The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients [clinicaltrials:NCT00001030]Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients [clinicaltrials:NCT00001039]Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS [clinicaltrials:NCT00001047]A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [clinicaltrials:NCT00001058]Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma [clinicaltrials:NCT00001318]Diagnostic Effectiveness of Virtual Bronchoscopy [clinicaltrials:NCT00001515]Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection [clinicaltrials:NCT00001763]Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections [clinicaltrials:NCT00001911]A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00001995]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002032]Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study [clinicaltrials:NCT00002037]A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease [clinicaltrials:NCT00002058]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study [clinicaltrials:NCT00002080]A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy [clinicaltrials:NCT00002085]An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy [clinicaltrials:NCT00002089]An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) [clinicaltrials:NCT00002090]A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo [clinicaltrials:NCT00002101]Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV [clinicaltrials:NCT00002104]A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients [clinicaltrials:NCT00002122]A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients [clinicaltrials:NCT00002140]A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC) [clinicaltrials:NCT00002170]Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. [clinicaltrials:NCT00002192]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002267]A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients [clinicaltrials:NCT00002309]The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS [clinicaltrials:NCT00002331]The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients [clinicaltrials:NCT00002336]A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00002343]Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections [clinicaltrials:NCT00004276]Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients [clinicaltrials:NCT00004296]Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease [clinicaltrials:NCT00004689]
condition browse [clinicaltrials_vocabulary:condition-browse]
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. [clinicaltrials:NCT00000641]A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS [clinicaltrials:NCT00000644]The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients [clinicaltrials:NCT00000860]Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy [clinicaltrials:NCT00000883]A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection [clinicaltrials:NCT00000895]A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients [clinicaltrials:NCT00000907]Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048 [clinicaltrials:NCT00000933]A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients [clinicaltrials:NCT00000947]The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS [clinicaltrials:NCT00000971]The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients [clinicaltrials:NCT00001023]The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients [clinicaltrials:NCT00001030]Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients [clinicaltrials:NCT00001039]Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS [clinicaltrials:NCT00001047]A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [clinicaltrials:NCT00001058]Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma [clinicaltrials:NCT00001318]Diagnostic Effectiveness of Virtual Bronchoscopy [clinicaltrials:NCT00001515]Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection [clinicaltrials:NCT00001763]Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections [clinicaltrials:NCT00001911]A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00001995]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002032]Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study [clinicaltrials:NCT00002037]A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease [clinicaltrials:NCT00002058]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study [clinicaltrials:NCT00002080]A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy [clinicaltrials:NCT00002085]An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy [clinicaltrials:NCT00002089]An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) [clinicaltrials:NCT00002090]A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo [clinicaltrials:NCT00002101]Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV [clinicaltrials:NCT00002104]A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients [clinicaltrials:NCT00002122]A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients [clinicaltrials:NCT00002140]A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC) [clinicaltrials:NCT00002170]Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. [clinicaltrials:NCT00002192]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002267]A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients [clinicaltrials:NCT00002309]The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS [clinicaltrials:NCT00002331]The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients [clinicaltrials:NCT00002336]A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00002343]Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections [clinicaltrials:NCT00004276]Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients [clinicaltrials:NCT00004296]Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease [clinicaltrials:NCT00004689]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Mycobacterium Infections [clinicaltrials_resource:c0b65b3beaf5acdac1e7869e44890a25]
Bio2RDF identifier
c0b65b3beaf5acdac1e7869e44890a25
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c0b65b3beaf5acdac1e7869e44890a25
identifier
clinicaltrials_resource:c0b65b3beaf5acdac1e7869e44890a25
title
Mycobacterium Infections
@en
type
label
Mycobacterium Infections [clinicaltrials_resource:c0b65b3beaf5acdac1e7869e44890a25]
@en
Mycobacterium Infections